Anxiety & Panic Latest News
- Older News
-
Clinicians Develop New Rating Scale for Perimenopausal Depression
Psychiatric News (Friday, 29 June) - Key differences in depressive symptoms that arise during perimenopause (the period immediately before menopause) suggest that perimenopausal depression may be a distinct subtype of depression, but scales to measure or... -
APA Urges Members to Maintain Pressure on Administration Regarding Child Detentions
Psychiatric News (Thursday, 21 June) - In an about-face, President Donald J. Trump signed an Executive Order yesterday halting his administration’s policy of separating migrant children from their parents who illegally cross the U.S. southern border.... -
Parent-Child Psychotherapy Leads to Improvements in Young Children With Depression
Psychiatric News (Wednesday, 20 June) - An adapted parent-child psychotherapy proven to help children with disruptive disorders may also reduce symptoms of depression in very young children, according to a study published today in AJP in... - Highlights From APA’s 2018 Annual Meeting: Issue #1
Psychiatric News (Friday, 15 June) - Everett Sums Up State of Psychiatry in America and Where Profession Is HeadedOne of the keys to psychiatry’s future is the development of innovative technologies that will reduce administrative burdens... - Anxiety: What it is, what to do
Harvard Mental Health Blog (Friday, 1 June) - Some anxiety in your life is normal and may be beneficial, but a response to anxiety that is out of proportion to the cause or source can be an indicator... -
APA Cautions Against Policy Separating Children From Parents at Border
Psychiatric News (Thursday, 31 May) - APA is urging an immediate halt to a new Trump administration policy that separates children from their parents at the U.S. border.“As physician experts in mental health, the American Psychiatric... -
Comorbid Medical Conditions May Point to Patients Most Likely to Develop Treatment-Resistant Depression
Psychiatric News (Wednesday, 30 May) - It is well known that some patients with depression will fail to respond to medications, but clinicians currently have few ways to predict those most likely to develop treatment-resistant depression... -
First Non-Opioid Medication Approved to Reduce Opioid Withdrawal Symptoms in Adults
Psychiatric News (Thursday, 17 May) - The Food and Drug Administration (FDA) on Wednesday announced the approval of Lucemyra (lofexidine hydrochloride) for the treatment of symptoms associated with opioid withdrawal in adults 18 and older. These...
- next >

